Current Rheumatology Reports

, Volume 2, Issue 2, pp 163–170

Paraneoplastic rheumatic syndromes

  • Hal J. Mitnick


Paraneoplastic rheumatic syndromes are challenging from both a clinical and research standpoint. Progress over the past decade has provided clarification of clinical syndromes. At the same time, our increasing ability to define and quantitate mediators of inflammation is shedding new light on pathogenesis. In turn, this understanding may answer questions regarding more common rheumatic diseases.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Naschitz JE, Rosner I, Rozenbaum M, et al.: Rheumatic syndromes: Clues to occult neoplasia. Semin Arthritis Rheum 1999, 29:43–55.PubMedCrossRefGoogle Scholar
  2. 2.
    Menon S, Isenberg DA: Rheumatological manifestations of haematological diseases. Ann Rheum Dis 1995, 54:787–795.PubMedGoogle Scholar
  3. 3.
    Seda H, Alarcon GS: Musculoskeletal syndromes associated with malignancies. Current Opin Rheum 1995, 7:48–53.Google Scholar
  4. 4.
    Kurzrock R, Cohen PR: Cutaneous paraneoplastic syndromes in solid tumors. Am J Med 1995, 99:662–671.PubMedCrossRefGoogle Scholar
  5. 5.
    Kurzrock R, Cohen PR: Mucocutaneous paraneoplastic manifestations of hematologic malignancies. Am J Med 1995, 99:207–216.PubMedCrossRefGoogle Scholar
  6. 6.
    Sheon RP, Kirsner AB, Tangsintanapas P, et al.: Malignancy in rheumatic diseases: interrelationships. J Amer Geriat Soc 1997, 25:20–27.Google Scholar
  7. 7.
    Bennet RM, Ginsberg MH, Thomsen S: Carcinomatous polyarthritis. The presenting symptom of an ovarian tumor and association with a platelet activating factor. Arthritis Rheum 1976, 19:953–958.CrossRefGoogle Scholar
  8. 8.
    Drenth JPH, de Kleijn EH, de Mulder PH, et al.: Metastatic breast cancer presenting as fever, rash, and arthritis. Cancer 1995, 75:1608–1611.PubMedCrossRefGoogle Scholar
  9. 9.
    Eggelmeijer F, Macfarlane JD: Polyarthritis as the presenting symptom of the occurrence and recurrence of a laryngeal carcinoma. Ann Rheum Dis 1992, 51:556–557.PubMedGoogle Scholar
  10. 10.
    Pauzner R, Istomin V, Segal-Lieberman G et al.: Bilateral patellar metastases as the clinical presentation of bronchogenic adenocarcinoma. J Rheum 1996, 23:939–941.PubMedGoogle Scholar
  11. 11.
    Chakravarty KK, Webley M: Monarthritis: an unusual presentation of renal cell carcinoma. Ann Rheum Dis 1992, 51:681–682.PubMedGoogle Scholar
  12. 12.
    Schwarzer AC, Fryer J, Preston SJ, et al.: Metastatic adenosquamous carcinoma presenting as an acute ankle monoarthritis, with a review of the literature. J Orthop Rheum 1990, 3:175–185.Google Scholar
  13. 13.
    Porter D, Madhok R, Capell H: Non-Hodgkins lymphoma in rheumatoid arthritis. Ann Rheum Dis 1991, 50:275–276.PubMedGoogle Scholar
  14. 14.
    Shokri F, Mageed RA, Maziak BR, et al.: Lymphoproliferation in primary Sjogren’s syndrome: evidence of selective expansion of a B cell subset characterized by the expression of crossreactive idiotypes. Arthritis Rheum 1993, 36:1128–1136.PubMedCrossRefGoogle Scholar
  15. 15.
    Fortin PR: Vasculitides associated with malignancy. Curr Opin Rheum 1996, 8:30–33.CrossRefGoogle Scholar
  16. 16.
    Tabata M, Kobayashi T: Polymyalgia rheumatica and thyroid papillary carcioma. Intern Med 1994, 33:41–44.PubMedGoogle Scholar
  17. 17.
    Sidhom OA, Basalaev M, Sigal LH: Renal cell carcinoma presenting as polymyalgia rheumatica. Arch Intern Med 1993, 153:2043–2045.PubMedCrossRefGoogle Scholar
  18. 18.
    Masin N, Buchard PA, Gerster JC: Polymyalgia rheumatica et cancer pulmonaire:syndrome paraneoplasique. Rev Rhum Mal Osteoartic 1992, 59:153–154.PubMedGoogle Scholar
  19. 19.
    Haga H-J, Eide GE, Brun J, et al.: Cancer in association with polymyalgia rheumatica and temporal arteritis. J Rheumatol 1993, 20:1335–1339.PubMedGoogle Scholar
  20. 20.
    Chuang TY, Hunder GG, Ilstrup DM: Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Int Med 1982, 97:672–680.PubMedGoogle Scholar
  21. 21.
    Shimamoto Y, Matsunaga C, Suga K, et al.: A human T-cell lymphotropic virus type I carrier with temporal arteritis terminating in acute myelogenous leukemia. Scand J Rheumatol 1994, 23:151–153.PubMedGoogle Scholar
  22. 22.
    Lie JT: Simultaneous clinical manifestations of malignancy and giant cell temporal arteritis in a young woman. J Rheumatol 1995, 22:367–369.PubMedGoogle Scholar
  23. 23.
    Holdrinet R, Corstens F, van Horn JR: Leukemic synovitis. Am J Med 1989, 86:123–124.PubMedCrossRefGoogle Scholar
  24. 24.
    Evans TI, Nercessian BM, Sanders KM: Leukemic arthritis. Semin Arthritis Rheum 1994, 24:48–56.PubMedCrossRefGoogle Scholar
  25. 25.
    McDonagh JE, Clarke F, Smith SR, et al.: Non-Hodgkin’s lymphoma presenting as polyarthritis. Br J Rheumatol 1994, 33:79–84.PubMedCrossRefGoogle Scholar
  26. 26.
    Roldan MR, Martinez F, Roman J, et al.: Non-Hodgkin’s lymphoma: initial manifestation: Ann Rheum Dis 1993, 52:85–86.PubMedGoogle Scholar
  27. 27.
    Schapira D, Kerner H, Scharf Y: Erosive arthritis in a patient with mycosis fungoides. J R Soc Med 1993, 86:176–177.PubMedGoogle Scholar
  28. 28.
    Mathur A, Parhami N: Arthritis mutilans associated with cutaneous T cell lymphoma. J Rheumatol 1992, 19:1489.PubMedGoogle Scholar
  29. 29.
    Menon N, Madhok R: Symmetrical polyarthritis is not always rheumatoid. Ann Rheum Dis 1994, 53:631–632.PubMedGoogle Scholar
  30. 30.
    Martinez-Lavin M, Matucci-Cerinic M, Jajic I, et al.: Hypertrophic osteoarthropathy: consensus on its definition, classification, assessment and diagnostic criteria. J Rheumatol 1993, 20:1386–1387.PubMedGoogle Scholar
  31. 31.
    Schumacher HR Jr: Hypertrophic osteoarthropathy: rheumatological manifestations. Clin Exp Rheumatol 1992, 10(suppl 7):35–40.PubMedGoogle Scholar
  32. 32.
    Dickinson CJ: The aetiology of clubbing and hypertrophic osteoarthropathy. Eur J Clin Invest 1993, 23:330–338PubMedGoogle Scholar
  33. 33.
    Dickinson CJ, Martin JF: Megakaryocytes and platelet clumps as the cause of finger clubbing. Lancet 1987, II:1434–1435.CrossRefGoogle Scholar
  34. 34.
    Silveri F, Carlino G, Cervini C: The "endothelium/platelet unit" in hypertrophic osteoarthropathy. Clin Exper Rheumatol 1992, 10:61–66.Google Scholar
  35. 35.
    Kahaleh MB: The role of vasuclar endothelium in fibroblast activation and tissue firbosis, particularly in scleroderma (systemic sclerosis) and pachydermoperiostosis (primary hypertrophic osteoarthropathy). Clin Exper Rheumatol 1992, 10:51–56.Google Scholar
  36. 36.
    Martinez-Lavin M: Pathogenesis of hypertrophic osteoarthropathy. Clin Eper Rheumatol 1992, 10:49–50.Google Scholar
  37. 37.
    Matucci-Cerinic M, Martinez-Lavin M, Rojo F, et al.: von Willebrand factor antigen in hypertrophic osteoarthropathy. J Rheumatol 1992, 19:765–767.PubMedGoogle Scholar
  38. 38.
    Kahtan S, Kahtan N: Unilateral finger clubbing. Lancet 1991, 338:576.PubMedCrossRefGoogle Scholar
  39. 39.
    Medsger T A, Dixon JA, Garwood VF: Palmar fasciitis and polyarthritis associated with ovarian carcinoma. Ann Intern Med 1982, 96:424–431.PubMedGoogle Scholar
  40. 40.
    Shiel C, Prete PE, Jason M, et al.: Palmar fasciitis and arthritis with ovarian and non-ovarian carcinomas. New syndrome. Am J Med 1985, 79:640–644.PubMedCrossRefGoogle Scholar
  41. 41.
    Champion D, Saxon JA, Kossard S: The syndrome of palmar fibromatosis (fasciitis) and polyarthritis. J Rheumatol 1987, 14:1196–1198.PubMedGoogle Scholar
  42. 42.
    Michaels RM, Sorber JA: Reflex sympathetic dystrophy as a probable paraneoplastic syndrome: case report and literature review. Arthritis Rheum 1984, 27:1183–1186.PubMedCrossRefGoogle Scholar
  43. 43.
    Leslie BM: Palmar fasciitis and polyarthritis associated with a malignant neoplasm: a paraneoplastic syndrome. Orthopedics 1992, 15:1436–1439.PubMedGoogle Scholar
  44. 44.
    Valverde-Garcia J, Juanola-Roura X, Ruiz-Maritn JM, et al.: Paraneoplastic palmar fasciitis-polyarthritis syndorme associated with breast cancer. J Rheumatol 1987, 14:1207–1209.PubMedGoogle Scholar
  45. 45.
    Hudson CN, Curling M, Potsides P, et al.: Paraneoplastic syndromes in patients with ovarian neoplaasia. J R Soc Med 1993, 86:202–204.PubMedGoogle Scholar
  46. 46.
    Virshup AM, Sliwinski AJ: Polyarthritis and subcutaneous nodules associated with carcinoma of the pancreas. Arthritis Rheum 1973, 16:388–392.PubMedCrossRefGoogle Scholar
  47. 47.
    Good A, Schnitzer B, Kawanishi H, et al.: Acinar pancreatic tumor with metastatic fat necrosis. Report of a case and review of rheumatic manifestations. Digest Dis 1976, 21:978–987.CrossRefGoogle Scholar
  48. 48.
    Plonk JW, Feldman JM: Carcinoid arthropathy. Arch Intern Med 1974, 134:651–654.PubMedCrossRefGoogle Scholar
  49. 49.
    Lambert CM, Nuki G: Multicentric reticulohistiocytosis with arthritis and cardiac infiltration: regression following treatment for underlying malignancy. Ann Rheum Dis 1992, 51:815–817.PubMedGoogle Scholar
  50. 50.
    Callen JP: Relationship of cancer to inflammatory muscle diseases. Rheum Dis Clin NA 1994, 20:943–953.Google Scholar
  51. 51.
    Zantos D, Zhang Y, Felson D: The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 1994, 21:1855–1859.PubMedGoogle Scholar
  52. 52.
    Ytterberg SR, Roelofs RI, Mahowald ML: Inclusion body myositis and renal cell carcinoma: report of two cases and review of the literature. Arthritis Rheum 1993, 36:416–421.PubMedCrossRefGoogle Scholar
  53. 53.
    Smith B: Skeletal muscle necrosis associated with carcinoma. J Pathol 1969, 97:207–210.PubMedCrossRefGoogle Scholar
  54. 54.
    Vosskamper M, Korf B, Franke F, et al.: Paraneoplastic necrotizing myopathy: a rare disorder to be differentiated from polymyositis. J Neurol 1989, 236:489–492.PubMedCrossRefGoogle Scholar
  55. 55.
    Naschitz JE, Yeshurun D, Dreyfuss U, et al.: Localized nodular myositis: a paraneoplastic phenomenon. Clin Rheumatol 1992, 11:427–431.PubMedCrossRefGoogle Scholar
  56. 56.
    Basten A, Bonnin M: Scleroderma in carcinoma. Med J Aust 1966, 1:452–452.PubMedGoogle Scholar
  57. 57.
    Schwartz RA, Burgess GH, Fox MD: Sclerodermoid changes in a patient with metastatic malignant melanoma. J Dermatol Surg Oncol 1980, 6:112–114.PubMedGoogle Scholar
  58. 58.
    Meyrier A, Becquemont L, Weill B, et al.: Hemolytic-uremic syndrome with anticariolipin antibodies revealing paraneoplastic systemic sleroderma. Nephron 1991, 59:493–496.PubMedGoogle Scholar
  59. 59.
    DeCross AJ, Sahasrabudhe DM: Paraneoplastic Raynaud’s phenomenon. Amer J Med 1992, 92:570–572.Google Scholar
  60. 60.
    Zuber M: Positive antinuclear antibodies in malignancies. Ann Rheum Dis 1992, 51:573–574.PubMedGoogle Scholar
  61. 61.
    Murashima A, Takasaki Y, Hashimoto, H, et al.: A case report of Raynaud’s disease with uterine cancer producing interleukin-6. Clin Rehumatol 1992, 11:410–412.CrossRefGoogle Scholar
  62. 62.
    Ogawa M, Ueda S, Ohto M, et al.: Development of systemic lupus erythematosus after total resection of a thymoma and the adjacent thymic gland. J Rheumatol 1992, 19:1130–1132.PubMedGoogle Scholar
  63. 63.
    Ascherman D, Katz P: Systemic lupus erythematosus, pemphigus erythematosus and thymoma in the same patient. JCR 1996, 2:152–155.PubMedGoogle Scholar
  64. 64.
    Chan LS, Hanson CA, Cooper KD: Concurrent eosinophilic fasciitis and cutaneous T-cell lymphoma. Eosinopholic fasciitis as a paraneoplastic syndrome of T-cell malignant neoplasms? Arch Dermatol 1991, 127:862–865.PubMedCrossRefGoogle Scholar
  65. 65.
    Naschitz JE, Yeshurun D, Zuckerman E, et al.: Cancer-associated fasciitis panniculitis. Cancer 1994, 73:231–235.PubMedCrossRefGoogle Scholar
  66. 66.
    Taillan B, Ferrari E, Fuzibet JG, et al.: Erythema nodosum and Hodgkin’s disease. Clin Rheumatol 1990, 9:397–398.PubMedCrossRefGoogle Scholar
  67. 67.
    Fortin PR, Esdaile JM: Vasculitis and malignancy. In Systemic Vasculidities, edn 1. Edited by Churg A, Churg J. New York:Igaku-Shoin; 1991:327–341.Google Scholar
  68. 68.
    Greer JM, Longley S, Edwards NL, et al.: Vasculitis associated with malignancy: experience with 13 patients and literature review. Medicine 1988, 67:220–230.PubMedCrossRefGoogle Scholar
  69. 69.
    Wooten MD, Jasin HE: Vasculitis and lymphoproliferatiave diseases. Semin Arthritis Rheum 1996, 26:564–574.PubMedCrossRefGoogle Scholar
  70. 70.
    Sanchez-Guerrero J, Gutierrez-Urena S, Vidaller A, et al.: Vasculitis as a paraneoplastic syndrome. Report of 11 cases and review of the literature. J. Rheumatol 1990, 17:1458–1462.PubMedGoogle Scholar
  71. 71.
    Castro M, Conn DL, Daniel Su WP, et al.: Rheumatic manifestations in myelodysplastic syndromes: J Rheumatol 1994, 18:721–727.Google Scholar
  72. 72.
    Kuzmich PV, Ecker GA, Karsh J: Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases. J Rheumatol 1994, 21:1649–1654.PubMedGoogle Scholar
  73. 73.
    Enright H, Jacob HS, Vercellotti G, et al.: Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy. Br J Haemoatol 1995, 91:403–408.Google Scholar
  74. 74.
    Shirota T, Hayashi O, Uchida H, et al.: Melodysplastic syndrome associated with relapsing polychondritis: unusual transformation from refractory anemia to chronic myelomonocytic leukemia. Ann Hematol 1993, 67:45–47.PubMedCrossRefGoogle Scholar
  75. 75.
    Van Besien K, Tricot G, Hoffman R: Relapsing polychondritis: a paraneoplastic syndrome assoicated with meyleodysplastic syndromes. Am J Hematol 1992, 40:47–50.PubMedCrossRefGoogle Scholar
  76. 76.
    Cohen PR, Kurzrock R: Sweet’s syndrome and malignancy. Am J Med 1987, 82:1220–1226.PubMedCrossRefGoogle Scholar
  77. 77.
    Fett DL, Gibson LE, Daniel Su WP: Sweet’s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 1995, 70:234–240.PubMedGoogle Scholar
  78. 78.
    George SW, Newman ED: Seronegative inflammatory arthritis in the myelodysplastic syndromes. Sem Arthritis Rheum 1992, 21:345–354.CrossRefGoogle Scholar
  79. 79.
    Kurzrock R, Cohen PR: Erythromelalgia: Review of clinical characteristics and pathophysiology. Am J Med 1991, 91:416–422.PubMedCrossRefGoogle Scholar
  80. 80.
    Elkon KB, Hughes GR, Catovsky D, et al.: Hairy-cell leukaemia with polyarteritis nodosa. Lancet 1979, II:280–282.CrossRefGoogle Scholar
  81. 81.
    Hasler P, Kistler H, Gerber H: Vasculitides in hairy cell leukemia. Semin Arthritis Rheum 1995, 25:134–142.PubMedCrossRefGoogle Scholar
  82. 82.
    Gabriel S, Conn D, Phyliky R, et al.: Vasculitis in hairy cell leukemia: review of the literature and consideration of possible pathogenic mechanisms. J Rheumatol 1986, 13:1167–1172.PubMedGoogle Scholar
  83. 83.
    Carpenter MT, West Sg: Polyarteritis nodosa in hairy cell leukemia: treatment with interferon-a. J Rheumatol 1994, 21:1150–1152.PubMedGoogle Scholar
  84. 84.
    Fernandez AM, Abeles M, Wong RL: Recurrent leukocytoclastic vasculitis as the intialmanifestation of acute myelomoncytic leukemia. J Rheumatol 1994, 21:1972–1974.PubMedGoogle Scholar
  85. 85.
    Bourantas K, Malamou-Mitsi VD, Chritsou L, et al.: Cutaneous vasculitis as the intial manifestation in acute myelomonocytic leukemia. Ann Intern Med 1994, 121:942–944.PubMedGoogle Scholar
  86. 86.
    Mautner G, Roth JS, Grossman ME: Leukocytoclastic vascultis in association with cryoglobulinemia and renal cell carcinoma. Nephron 1993, 63:356–357.PubMedGoogle Scholar
  87. 87.
    Ruiz-Maldonato R, Parilla FM, Orozco-Covarrubias MD, et al.: Edematous scarring vasculitic panniculitis: an new multisystemic disease with malignant potential. J Am Acad Dermatol 32:37–44 1995.CrossRefGoogle Scholar
  88. 88.
    Oh SJ, Slaughter R, Harrell L: Paraneoplastic vasculitic neuropathy: a treatable neuropathy. Muscle Nerve 1991, 14:152–156.PubMedCrossRefGoogle Scholar
  89. 89.
    Dropcho EJ: Autoimmune aspects of neurologic paraneoplastic syndromes. Clin Asp Autoimm 1989, 4:8–22.Google Scholar
  90. 90.
    Posner JB: Paraneoplastic syndromes. Neurol Clin 1991, 9:919–936.PubMedGoogle Scholar
  91. 91.
    Stubgen J-P: Neuromuscular disorders in systemic malignancy and its treatment. Muscle Nerve 1995, 18:636–648.PubMedCrossRefGoogle Scholar
  92. 92.
    McMillen JJ, Krueger SK, Dyer GA: Leukocytoclastic vasculitis in association with immunoglobulin A myeloma. Ann Intern Med 1986, 105:709–710.PubMedGoogle Scholar
  93. 93.
    Duna GF, Cash JM: Rheumatic manifestations of dysproteinemias and lymphoproliferative disroders. Rheum Dis Clin NA 1996, 22:39–51.CrossRefGoogle Scholar
  94. 94.
    Rivest C, Pierre-Paul T, Senecal J-L: Lambda light chain deposition disease presenting as an amyloid-like arthropathy. J Rheumatol 1993, 20:880–884.PubMedGoogle Scholar
  95. 95.
    Aucouturier P, Khamlichi AA, Touchard G, et al.: Brief report: Heavy-chain deposition disease. NEJM 1993, 329:1389–1393.PubMedCrossRefGoogle Scholar
  96. 96.
    Miralles GD, O’Fallon JR, Talley N: Plasma-cell dyscrasia with polyneuropathy: The spectrum of POEMS syndrome. NEJM 1992, 327:1919–1923.PubMedGoogle Scholar
  97. 97.
    Murphy N, Schumacher HR: POEMS syndrome in systemic lupus erythematosus. J Rheumatol 1992, 19:796–799.PubMedGoogle Scholar
  98. 98.
    Navarro PH, Bravo FP, Beltran GG: Atrial myxoma with livedoid macules as its sole cutaneous manifestations. J AM Acad Dermatol 1995, 32:881–883.PubMedCrossRefGoogle Scholar
  99. 99.
    Lie JT: Malignant angioendotheliomatosis (intravascular lymphomatosis) clinically simulating primary angiitis of the central nervous system. Arthritis Rheum 1992, 35:831–834.PubMedCrossRefGoogle Scholar
  100. 100.
    Kao NL, Broy S, Tillawi I: Malignant angioendotheliomatosis mimicking systemic necrotizing vasculitis. J Rheumatol 19:1133–1135 1992.PubMedGoogle Scholar
  101. 101.
    Legerton CW, Sergent JS: Intravascular malignant lymphoma mimicking central nervous system lupus. Arthritis Rheum 1993, 36:135.PubMedCrossRefGoogle Scholar
  102. 102.
    Thomas R, Vuitch F, Lakhanpal S: Angiocentric T cell lymphoma masquerading as cutaneous vasculitis. J Rheumatol 1994, 21:760–762.PubMedGoogle Scholar
  103. 103.
    Tefferi A, Li C-Y, Witzig TE, et al.: Chronic natural killer cell lymphocytosis: a descriptive clinical study. Blood 1994, 84:2721–2725.PubMedGoogle Scholar
  104. 104.
    Loprinzi CL, Duffy J, Ingle JN: Postchemotherapy rheumatism. J Clin Oncol 1993, 11:768–770.PubMedGoogle Scholar
  105. 105.
    Rosenstein ED, Kramer N, Leitner SP: Exacerbation of rheumatoid arthtitis after termination of chemotherapy for breast carcinoma. J Rheumatol 1996, 23:1988–1990.PubMedGoogle Scholar
  106. 106.
    Craemer P, Lim K, George E, et al.: Acute inflammatory polyarthritis in association with tamoxifen. Br J Rheumatol 1994, 33:583–585.CrossRefGoogle Scholar
  107. 107.
    Drago F, Arditi M, Rebora A: Tamoxifen and purpuric vasculitis. Ann Intern Med 1990, 112:965–966.PubMedGoogle Scholar
  108. 108.
    Ronnblom LE, Alm GV, Oberg KE: Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann Int Med 1991, 115:178–183.PubMedGoogle Scholar
  109. 109.
    Chazerain P, Meyer O, Kahn M-F: Rheumatoid arthritis-like disease after alpha-interferon. Ann Int Med 1992, 116:427.PubMedGoogle Scholar
  110. 110.
    Ueno Y, Sohma T: Alpha-interferon-induced nodular rheumatoid arthritis in renal cell carcinoma. Ann Intern Med 1992, 117:266–267.PubMedGoogle Scholar
  111. 111.
    Scheinbenbogen C, Keilholz U, Pezzutto A, et al.: Rheumatic diseases folllowing immunotherapy. Ann Rheum Dis 1993, 52:165.CrossRefGoogle Scholar
  112. 112.
    Goupille P, Soutif D, Valat J-P: Arthritis after Calmette-Guerin Bacillus immunotherapy for bladder cancer. J Rheumatol 1992, 19:1825–1826.PubMedGoogle Scholar
  113. 113.
    Jawad ASM, Kahn L, Copland RPF, et al.: Reactive arthritis associated with Bacillus Calmette-Guerin immunotherapy for carcinoma of the bladder: a report of two cases. Br J Rheumatol 1993, 32:1018–1020.PubMedCrossRefGoogle Scholar
  114. 114.
    Johnson ML, Grimwood RE: Leukocyte colony-stimulating factors. A review of associated neutrophilic dermatoses and vasculitides. Arch Dermatol 1994, 130:77–81.PubMedCrossRefGoogle Scholar
  115. 115.
    Dreicer R, Schiller J, Carbone PP: Granulocyte-macrophage colony-stimulating factor and vasculitis. Ann Intern Med 1989, 111:91–92.PubMedGoogle Scholar
  116. 116.
    Agarwala Sanjiv: Paraneoplastic syndromes. Med Clin NA 1996, 80:173–184.Google Scholar
  117. 117.
    Richardson GE, Johnson BE: Paraneoplastic syndromes in lung cancer. Curr Opin Oncol 1992, 4:323–333.PubMedCrossRefGoogle Scholar
  118. 118.
    Schapira D, Ben Izhak O, Nachtigal A, et al.: Tumor induced osteomalacia. Semin Arthritis Rheum 1995, 25:35–46.PubMedCrossRefGoogle Scholar
  119. 119.
    Kremer R, Shustik C, Tabak, T, et al.: Parathyroid-hormonerelated peptide in hematologic malignancies. Am J Med 1996, 100:406–411.PubMedCrossRefGoogle Scholar
  120. 120.
    Nabriski D, Shenkman L, Shapiro MS: Chronic rheumatic disorder as the primary manifestation of hypopituitarism caused by a pituitary tumor. Isr J Med Sci 1989, 25:715–716.PubMedGoogle Scholar
  121. 121.
    Yunus M, Masi AT, Allen JP: Hypothalamic Hypopituitarism presenting with rheumatic symptoms. Arthritis Rheum 1981, 24:632–635.PubMedCrossRefGoogle Scholar
  122. 122.
    Shahidid H, Myers JL, Kvale PA: Castleman’s disease. Mayo Clin Proc 1995, 70:969–977.CrossRefGoogle Scholar
  123. 123.
    Beck JT, Hsu S-M, Wijdenes J, et al.: Brief report: alleviation of systemic manifestations of Castelman’s disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 1994, 330:602–605.PubMedCrossRefGoogle Scholar
  124. 124.
    Davies KA, Cope AP, Schofield JB, et al.: A rare mediastinal tumor presenting with systemic effects due to IL-6 and tumor necrosis factor (TNF) production. Clin Exp Immunol 1995, 99:117–123.PubMedCrossRefGoogle Scholar
  125. 125.
    Fukumoto S, Matsumoto T, Harada S, et al.: Pheochromocytoma with pyrexia and marked inflammatory signs: a paraneoplastic syndrome with possible relation to interleukin-6 production. J Clin Endocrinol Metab 1991, 73:877–881.PubMedCrossRefGoogle Scholar
  126. 126.
    Strassmann G, Jacob CO, Fong M, et al.: Mechanisms of paraneoplastic syndromes of colon-26: involvement of interleukin 6 in hypercalcemia. Ctyokine 1993, 5:463–468.Google Scholar
  127. 127.
    Gherardi RK, Chouaib S, Malapert D, et al.: Early weight loss and high serum tumor necrosis factor-alpha levels in polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome. Ann Neurol 1994, 35:501–505.PubMedCrossRefGoogle Scholar
  128. 128.
    Gherardi RK Belec L, Fromont G, et al.: Elevated levels of interleukin-1b and IL-6 in serum and increased production of IL-1b mRNA in lymph nodes of patients with polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes (POEMS) syndrome. Blood 1994, 83:2587–2593.PubMedGoogle Scholar
  129. 129.
    Fukatsu A, Ito Y, Yuzawa Y, et al.: A case of POEMS syndrome showing elevated serum interleukin 6 and abnormal expression of interleukin 6 in the kidney. Nephron 1992, 62:47–51.PubMedGoogle Scholar

Copyright information

© Current Science Inc. 2000

Authors and Affiliations

  • Hal J. Mitnick
    • 1
  1. 1.Division of RheumatologyNew York University School of MedicineNew YorkUSA

Personalised recommendations